REGENERON PHARMACEUTICALS INC
Acción · US75886F1075 · REGN · 881535 (XNAS)
494,00 USD
06.06.2025 20:42
Cotizaciones actuales de REGENERON PHARMACEUTICALS INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
REGN
|
USD
|
06.06.2025 20:42
|
494,00 USD
| 483,07 USD
+2,26 %
|
![]() London |
0R2M.L
|
USD
|
06.06.2025 15:13
|
496,04 USD
| 483,07 USD
+2,68 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 0,55 % | -11,55 % | -29,27 % | -36,39 % | -50,84 % | -17,25 % |
Perfil de la empresa para REGENERON PHARMACEUTICALS INC Acción
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Fondos invertidos
Los siguientes fondos han invertido en: REGENERON PHARMACEUTICALS INC invertido:
Fondo | Vol. en millones 2.094,68 | Porcentaje (%) 4,91 % |
Fondo | Vol. en millones 23.196,45 | Porcentaje (%) 1,33 % |
Fondo | Vol. en millones 1.295,63 | Porcentaje (%) 1,25 % |
Fondo | Vol. en millones 33,86 | Porcentaje (%) 1,25 % |
Fondo | Vol. en millones 3.294,59 | Porcentaje (%) 0,90 % |
Datos de la empresa
Nombre REGENERON PHARMACEUTICALS INC
Empresa Regeneron Pharmaceuticals, Inc.
Símbolo REGN
Sitio web
https://www.regeneron.com
Mercado principal
NASDAQ

WKN 881535
ISIN US75886F1075
Tipo de valor Acción
Sector Healthcare
Industria Medical - Pharmaceuticals
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Capitalización de mercado 60 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 15,1 T
Dirección 777 Old Saw Mill River Road, 10591-6707 Tarrytown
Fecha de OPV 2014-11-05
Dividendos de 'REGENERON PHARMACEUTICALS INC'
Fecha ex-dividendo | Dividendo por acción |
---|---|
20.05.2025 | 0,88 USD |
20.02.2025 | 0,88 USD |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | RGO.F |
London | 0R2M.L |
NASDAQ | REGN |
Otras acciones
Los inversores que tienen REGENERON PHARMACEUTICALS INC también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.